Work

Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to Docetaxel in CRMPC

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-09-3026

Authors: Roberto Pili, Mark A. Rosenthal, Paul N. Mainwaring, Guy Van Hazel, Sandy Srinivas, Robert Dreicer, Sanjay Goel, Joseph Leach, Shirley Wong, Peter Clingan

Institutions: Albert Einstein College of Medicine, The Royal Melbourne Hospital, Montefiore Medical Center, Johns Hopkins University, Stanford University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2144813855

FWCI: 8.268

Cites: 27

Cited by: 62

Related to: 10